Table 3. The risk of VTE in patients with uterine leiomyomas in different age group after excluding those receiving hormone therapy.

Subgroup	Before matching data		Frequency matched data		Propensity score matched data
	Adjusted odds ratio (95% CI)	p value	Adjusted odds ratio (95% CI)	p value	Adjusted odds ratio (95% CI)	p value
≤ 30	4.602 (1.21-17.44)	0.0247	6.407 (1.57-26.2)	0.0097	5.927 (1.45-24.24)	0.0133
31-40	1.212 (0.55-2.69)	0.636	1.361 (0.61-3.05)	0.4534	0.951 (0.42-2.16)	0.9049
41-50	1.535 (1.10-2.15)	0.0129	1.607 (1.04-2.47)	0.031	1.468 (1.05-2.05)	0.0231
51-60	1.203 (0.83-1.74)	0.3268	1.213 (0.84-1.75)	0.3034	1.183 (0.82-1.70)	0.3626
≥ 61	1.076 (0.60-1.93)	0.8053	1.056 (0.47- 2.37)	0.8943	0.956 (0.53-1.74)	0.956